The manufacturers of the machines that run our DNA are still very much in the forefront, gaining investors with DNA sequencing. BD NEW YORK (GenomeWeb News) – Menlo Park, Calif.-based Pacific Biosciences today said that it recently received $20 million in funding from new investor Blackstone Cleantech...
It is still at the mice testing stage, but 80% tested had a reversal of diabetes and in other cases it prevented the onset of diabetes. Side effects, etc. will need to be studied as well, but this looks very promising if in fact the drugs can prevent diabetes for many, especially children if their...
Posted to
The Medical Quack .... by Barbara Duck
on 11-19-2008
Filed under: Medically Related, Pharma/FDA News, personalized medicine, healthcare, Cancer, Diabetes, R and D, San Francisco University of California
Personalized Medicine will create many answers and solutions in healthcare, but will we have the money to afford it? I post quite a bit about genomics and personalized medicine on the blog here and the one thing it has in common with the rest of healthcare is cost. The success of personalized...
Posted to
The Medical Quack .... by Barbara Duck
on 11-14-2008
Filed under: Medically Related, Technology, Insurance, Other Items of Interest, personalized medicine, healthcare, Medical Records, FDA, integration, CMS, Leavitt
New abbreviation here to become acquainted with (PGx) which is pharmacogenics, and one more move in the direction of personalized medicine by big Pharma as the marketing of blockbuster drugs slowly evolves to a new business model with genomic data input becoming a part of the process to bring new drugs...
Posted to
The Medical Quack .... by Barbara Duck
on 11-06-2008
Filed under: Medically Related, Technology, personalized medicine, Genomics, healthcare, Pharma, Pharmacogenomics, Lilly, Pharmacogenetics
The American Medical Association administration recommends that genetic testing be carried out under the personal supervision of a qualified health care professional, but the lines get a bit gray in between what is actual clinical credible data and what is still science. Education of both the physicians...
Posted to
The Medical Quack .... by Barbara Duck
on 11-04-2008
Filed under: Medically Related, Technology, Insurance, Pharma/FDA News, personalized medicine, Genomics, healthcare, Science, AMA, DNA Testing, Sequencing, Lab Tests, genetic counselors
It is here but evolving slower than what all of us might like to see, and in many areas it is still so much of a “Science” but as developments occur through biotech we are seeing some amazing results. There’s also the bridging of the gap with bringing genomics to the point of care, as physicians...
Posted to
The Medical Quack .... by Barbara Duck
on 10-26-2008
Filed under: Medically Related, Technology, Pharma/FDA News, personalized medicine, healthcare, Pharma, Biotech, Cancer, tumors, Genentech, Herceptin, cancer vaccine
One thing that comes to mind is what a waste of talent here. Series of events lead up to where he is today, but started when he ran out of money for his research related to the GFP gene and cancer. “Researchers worldwide now use GFP to track development of brain cells, the growth of tumors...
Posted to
The Medical Quack .... by Barbara Duck
on 10-14-2008
Filed under: Medically Related, Technology, Pharma/FDA News, personalized medicine, Genomics, healthcare, Cancer, R and D, GFP Gene, Nobel Prize